Insight Molecular Diagnostics (IMDX) Amortizatization of Intangibles (2020 - 2025)
Historic Amortizatization of Intangibles for Insight Molecular Diagnostics (IMDX) over the last 6 years, with Q1 2025 value amounting to $7000.0.
- Insight Molecular Diagnostics' Amortizatization of Intangibles fell 6818.18% to $7000.0 in Q1 2025 from the same period last year, while for Sep 2025 it was $29000.0, marking a year-over-year decrease of 6704.55%. This contributed to the annual value of $88000.0 for FY2024, which is 0.0% changed from last year.
- As of Q1 2025, Insight Molecular Diagnostics' Amortizatization of Intangibles stood at $7000.0, which was down 6818.18% from $22000.0 recorded in Q4 2024.
- Insight Molecular Diagnostics' Amortizatization of Intangibles' 5-year high stood at $1.1 million during Q2 2021, with a 5-year trough of $7000.0 in Q1 2025.
- Its 5-year average for Amortizatization of Intangibles is $424470.6, with a median of $22000.0 in 2023.
- As far as peak fluctuations go, Insight Molecular Diagnostics' Amortizatization of Intangibles surged by 478181.82% in 2021, and later tumbled by 9774.59% in 2023.
- Insight Molecular Diagnostics' Amortizatization of Intangibles (Quarter) stood at $990000.0 in 2021, then dropped by 20.0% to $792000.0 in 2022, then crashed by 97.22% to $22000.0 in 2023, then changed by 0.0% to $22000.0 in 2024, then crashed by 68.18% to $7000.0 in 2025.
- Its Amortizatization of Intangibles was $7000.0 in Q1 2025, compared to $22000.0 in Q4 2024 and $22000.0 in Q3 2024.